ENDECE to Present Data at the 2016 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress

ENDECE will present “A small molecule therapy for MS patients appears to override inhibitors of oligodendrogenesis to induce remyelination” during a poster session at the 2016 European Committee for Treatment of Research in Multiple Sclerosis Congress (ECTRIMS) in London, United Kingdom.

 

WHERE: Poster Exhibition, ExCeL London, One Western Gateway, Royal Victoria Dock
WHEN: Friday, September 16, 3:30-5:00 PM GMT
CATEGORY: Disease Modification

Submit a Comment

Your email address will not be published. Required fields are marked *